HomeCPRX • NASDAQ
add
Catalyst Pharmaceuticals Inc
Previous close
$22.80
Day range
$22.80 - $23.39
Year range
$19.05 - $26.58
Market cap
2.82B USD
Avg Volume
1.33M
P/E ratio
17.66
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 148.39M | 15.31% |
Operating expense | 56.81M | 2.88% |
Net income | 52.78M | 20.28% |
Net profit margin | 35.57 | 4.31% |
Earnings per share | 0.68 | 19.30% |
EBITDA | 75.68M | 25.39% |
Effective tax rate | 25.69% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 689.89M | 55.97% |
Total assets | 1.05B | 36.22% |
Total liabilities | 131.36M | 18.27% |
Total equity | 920.24M | — |
Shares outstanding | 122.91M | — |
Price to book | 3.05 | — |
Return on assets | 16.37% | — |
Return on capital | 18.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 52.78M | 20.28% |
Cash from operations | 32.44M | -55.49% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 4.65M | 177.90% |
Net change in cash | 37.09M | -44.34% |
Free cash flow | 15.60M | -74.25% |
About
Founded
2002
Headquarters
Website
Employees
181
